<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE HTML>
<html xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" lang="en">
  <head>
    <meta content="text/html;charset=utf-8" http-equiv="Content-Type"/>
    <title>Document Bundle - Prostatabiopsie - Prostate Cancer Specification v0.1.0</title>

    <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
    <meta name="author" content="http://hl7.org/fhir"/>

    <link href="fhir.css" rel="stylesheet"/>

    <!-- Bootstrap core CSS -->
    <link href="assets/css/bootstrap-fhir.css" rel="stylesheet"/>

    <!-- Project extras -->
    <link href="assets/css/project.css" rel="stylesheet"/>
    <link href="assets/css/pygments-manni.css" rel="stylesheet"/>
    <link href="assets/css/jquery-ui.css" rel="stylesheet"/>
  	<link href="assets/css/prism.css" rel="stylesheet" />
  	<link href="assets/css/cqf.css" rel="stylesheet" />
    <!-- Placeholder for child template CSS declarations -->

    <script type="text/javascript" src="fhir-table-scripts.js"> </script>

    <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
    <script src="assets/js/html5shiv.js"></script>
    <script src="assets/js/respond.min.js"></script>
    <![endif]-->

    <!-- Favicons -->
    <link rel="apple-touch-icon-precomposed" sizes="144x144" href="assets/ico/icon-fhir-144.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="114x114" href="assets/ico/icon-fhir-114.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="72x72" href="assets/ico/icon-fhir-72.png"/>
    <link rel="apple-touch-icon-precomposed" href="assets/ico/icon-fhir-57.png"/>
    <link rel="shortcut icon" href="assets/ico/favicon.png"/>
  </head>
  <body onload="document.body.style.opacity='1'">

	  <script src="assets/js/prism.js"></script>
    <script type="text/javascript" src="assets/js/mermaid.js"></script>
    <script type="text/javascript" src="assets/js/mermaid-init.js"></script>
    <style type="text/css">h2{--heading-prefix:"9.30"}
    h3,h4,h5,h6{--heading-prefix:"9.30"}</style>
    <div id="segment-header" class="segment">  <!-- segment-header -->
      <div class="container">  <!-- container -->

        <!-- Placeholder for child template header declarations -->


        <div id="ig-status">
          <p><span style="font-size:12pt;font-weight:bold">Prostate Cancer Specification</span>
            <br/>
            <span style="display:inline-block;">0.1.0 - ci-build


            </span>
          </p>
        </div>
      </div> <!-- /container -->
    </div>  <!-- /segment-header -->

    <div id="segment-navbar" class="segment">  <!-- segment-navbar -->
      <div id="stripe"> </div>
      <div class="container">  <!-- container -->
        <!-- HEADER CONTENT -->

        <nav class="navbar navbar-inverse">
          <!--status-bar-->
          <div class="container">
            <button data-target=".navbar-inverse-collapse" class="navbar-toggle" data-toggle="collapse" type="button">
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
            </button>
            <a class="navbar-brand hidden" href="http://hl7.org/fhir/R4/index.html">FHIR</a>
            <div class="nav-collapse collapse navbar-inverse-collapse">
              <!-- menu.xml  -->

<ul xmlns="http://www.w3.org/1999/xhtml" class="nav navbar-nav">
  <li>
    <a href="index.html">Home</a>
  </li>
  <li>
    <a href="clinical-context.html">Clinical Context</a>
  </li>
  <li>
    <a href="motivation.html">Motivation</a>
  </li>
  <li>
    <a href="document-viewer.html">Befund-Viewer</a>
  </li>
  <li class="dropdown">
    <a data-toggle="dropdown" href="#" class="dropdown-toggle">Core Needle Biopsy
      <b class="caret"></b>
    </a>
    <ul class="dropdown-menu">
      <li>
        <a href="ServiceRequest-CoreNeedleBiopsyReportRequest.html">ServiceRequest</a>
      </li>
      <li>
        <a href="biopsy-specimens.html">Specimens</a>
      </li>
      <li>
        <a href="Observation-CoreNeedleBiopsyMacroscopicGrouper.html">MacroscopyGrouper</a>
      </li>
      <li>
        <a href="Observation-CoreNeedleBiopsyMicroscopicGrouper.html">MicroscopyGrouper</a>
      </li>
      <li>
        <a href="Observation-CoreNeedleBiopsyDiagnosticConclusionGrouper.html">DiagnosticConclusionGrouper</a>
      </li>
      <li>
        <a href="DiagnosticReport-CoreNeedleBiopsyReport.html">DiagnosticReport</a>
      </li>
      <li>
        <a href="Composition-CoreNeedleBiopsyComposition.html">Composition</a>
      </li>
    </ul>
  </li>
  <li class="dropdown">
    <a data-toggle="dropdown" href="#" class="dropdown-toggle">Prostatectomy
      <b class="caret"></b>
    </a>
    <ul class="dropdown-menu">
      <li>
        <a href="ServiceRequest-RadicalProstatectomyReportRequest.html">ServiceRequest</a>
      </li>
      <li>
        <a href="prostatectomy-specimens.html">Specimens</a>
      </li>
      <li>
        <a href="Observation-RadicalProstatectomyMacroscopicGrouper.html">MacroscopyGrouper</a>
      </li>
      <li>
        <a href="Observation-RadicalProstatectomyDiagnosticConclusionGrouper.html">DiagnosticConclusionGrouper</a>
      </li>
      <li>
        <a href="DiagnosticReport-RadicalProstatectomyReport.html">DiagnosticReport</a>
      </li>
      <li>
        <a href="Composition-RadicalProstatectomyComposition.html">Composition</a>
      </li>
    </ul>
  </li>
  <li class="dropdown">
    <a data-toggle="dropdown" href="#" class="dropdown-toggle">TUR Enucleation
      <b class="caret"></b>
    </a>
    <ul class="dropdown-menu">
      <li>
        <a href="ServiceRequest-TransurethralEnucleationReportRequest.html">ServiceRequest</a>
      </li>
      <li>
        <a href="tur-enucleation-specimens.html">Specimens</a>
      </li>
      <li>
        <a href="Observation-TransurethralEnucleationMacroscopicGrouper.html">MacroscopyGrouper</a>
      </li>
      <li>
        <a href="Observation-TransurethralEnucleationDiagnosticConclusionGrouper.html">DiagnosticConclusionGrouper</a>
      </li>
      <li>
        <a href="DiagnosticReport-TransurethralEnucleationReport.html">DiagnosticReport</a>
      </li>
      <li>
        <a href="Composition-TransurethralEnucleationComposition.html">Composition</a>
      </li>
    </ul>
  </li>
  <li class="dropdown">
    <a data-toggle="dropdown" href="#" class="dropdown-toggle">TUR Resection
      <b class="caret"></b>
    </a>
    <ul class="dropdown-menu">
      <li>
        <a href="ServiceRequest-TransurethralResectionReportRequest.html">ServiceRequest</a>
      </li>
      <li>
        <a href="tur-resection-specimens.html">Specimens</a>
      </li>
      <li>
        <a href="Observation-TransurethralResectionMacroscopicGrouper.html">MacroscopyGrouper</a>
      </li>
      <li>
        <a href="Observation-TransurethralResectionDiagnosticConclusionGrouper.html">DiagnosticConclusionGrouper</a>
      </li>
      <li>
        <a href="DiagnosticReport-TransurethralResectionReport.html">DiagnosticReport</a>
      </li>
      <li>
        <a href="Composition-TransurethralResectionComposition.html">Composition</a>
      </li>
    </ul>
  </li>
  <li>
    <a href="artifacts.html">Artifacts</a>
  </li>
</ul>
            </div>  <!-- /.nav-collapse -->
          </div>  <!-- /.container -->
        </nav>  <!-- /.navbar -->
      <!-- /HEADER CONTENT -->
      </div>  <!-- /container -->
    </div>  <!-- /segment-navbar -->
    <!--status-bar-->

    <div id="segment-breadcrumb" class="segment">  <!-- segment-breadcrumb -->
      <div class="container">  <!-- container -->
        <ul class="breadcrumb">
          <li><a href='toc.html'><b>Table of Contents</b></a></li><li><a href='artifacts.html'><b>Artifacts Summary</b></a></li><li><b>Document Bundle - Prostatabiopsie</b></li>

        </ul>
      </div>  <!-- /container -->
    </div>  <!-- /segment-breadcrumb -->

    <a name="top"> </a>
    <div id="segment-content" class="segment">  <!-- segment-content -->
      <div class="container">  <!-- container -->
        <div class="row">
          <div class="inner-wrapper">

<div class="col-12">
  <!--ReleaseHeader--><p id="publish-box">Prostate Cancer Specification - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the <a href='http://prostatecancerspec.org/history.html'>Directory of published versions</a></p><!--EndReleaseHeader-->

  








<ul class="nav nav-tabs">

  <li class="active">
    <a href="#">Narrative Content</a>
  </li>



  
    <li>
      <a href="Bundle-CoreNeedleBiopsyDocument.xml.html">XML</a>
    </li>
  


  
    <li>
      <a href="Bundle-CoreNeedleBiopsyDocument.json.html">JSON</a>
    </li>
  


  
    <li>
      <a href="Bundle-CoreNeedleBiopsyDocument.ttl.html">TTL</a>
    </li>
  



</ul>


  <a name="root"> </a>


  <h2 id="root">Example Bundle: Document Bundle - Prostatabiopsie</h2>




  <!-- insert intro if present -->
  



  <div data-fhir="generated"><div style="border: 1px solid maroon; padding: 10px; background-color: #f2faf9; min-height: 160px;"><p><b>Document Details</b></p><p class="res-header-id"/><a name="CoreNeedleBiopsyDocument"> </a><a name="hcCoreNeedleBiopsyDocument"> </a></div><div style="border: 1px solid maroon; padding: 10px; background-color: #f2faf9; min-height: 160px;"><p><b>Document Subject</b></p><p class="res-header-id"/><a name="CoreNeedleBiopsyDocument/Patient1"> </a><a name="hcCoreNeedleBiopsyDocument/Patient1"> </a><p style="border: 1px #661aff solid; background-color: #e6e6ff; padding: 10px;">Hans Mueller  Male, DoB: 1955-08-15 ( http://example.hospital.de/patient-ids#PAT-2024-001)</p><hr/></div><hr/><div style="border: 1px solid maroon; padding: 10px; background-color: #f2faf9; min-height: 160px;"><p><b>Document Content</b></p><div><h2>Pathologiebefundbericht</h2></div><h3>Klinische Angaben</h3><p>Erhöhter PSA-Wert (8,5 ng/ml). V.a. Prostatakarzinom. Bitte histologische Abklärung.</p><h3>Makroskopie</h3><table border="1" cellpadding="4" cellspacing="0"><thead><tr><th>Stanze</th><th>Lokalisation</th><th>Länge (cm)</th><th>Zylinder</th></tr></thead><tbody><tr><td>01</td><td>Rechts apikal</td><td>1.2</td><td>2</td></tr><tr><td>02</td><td>Rechts medial</td><td>1.5</td><td>2</td></tr><tr><td>03</td><td>Rechts basal</td><td>1.3</td><td>2</td></tr><tr><td>04</td><td>Rechts lateral apikal</td><td>1.4</td><td>2</td></tr><tr><td>05</td><td>Rechts lateral medial</td><td>1.6</td><td>2</td></tr><tr><td>06</td><td>Rechts lateral basal</td><td>1.1</td><td>2</td></tr><tr><td>07</td><td>Links apikal</td><td>1.3</td><td>2</td></tr><tr><td>08</td><td>Links medial</td><td>1.4</td><td>2</td></tr><tr><td>09</td><td>Links basal</td><td>1.2</td><td>2</td></tr><tr><td>10</td><td>Links lateral apikal</td><td>1.5</td><td>2</td></tr><tr><td>11</td><td>Links lateral medial</td><td>1.3</td><td>2</td></tr><tr><td>12</td><td>Links lateral basal</td><td>1.4</td><td>2</td></tr></tbody></table><h3>Mikroskopie</h3><table border="1" cellpadding="4" cellspacing="0"><thead><tr><th>Stanze</th><th>Befund</th><th>Gleason</th><th>Tumoranteil</th></tr></thead><tbody><tr><td>01</td><td>Adenokarzinom</td><td>3+4=7</td><td>40%</td></tr><tr><td>02</td><td>Adenokarzinom</td><td>4+3=7</td><td>60%</td></tr><tr><td>03</td><td>Benigne</td><td>-</td><td>-</td></tr><tr><td>04</td><td>Adenokarzinom</td><td>3+4=7</td><td>35%</td></tr><tr><td>05</td><td>Benigne</td><td>-</td><td>-</td></tr><tr><td>06</td><td>Benigne</td><td>-</td><td>-</td></tr><tr><td>07</td><td>Adenokarzinom</td><td>3+4=7</td><td>45%</td></tr><tr><td>08</td><td>Benigne</td><td>-</td><td>-</td></tr><tr><td>09</td><td>Benigne</td><td>-</td><td>-</td></tr><tr><td>10</td><td>Benigne</td><td>-</td><td>-</td></tr><tr><td>11</td><td>Benigne</td><td>-</td><td>-</td></tr><tr><td>12</td><td>Benigne</td><td>-</td><td>-</td></tr></tbody></table><h3>Diagnostische Schlussfolgerung</h3><p><b>Diagnose:</b> Azinäres Adenokarzinom der Prostata (ICD-O 8140/3)</p><table border="1" cellpadding="4" cellspacing="0"><tbody><tr><td>Histologischer Typ</td><td>Azinäres Adenokarzinom (8140/3)</td></tr><tr><td>Gleason-Score</td><td>3+4=7a</td></tr><tr><td>ISUP-Gradgruppe</td><td>2 (WHO 2016)</td></tr><tr><td>Positive Stanzen</td><td>7 von 12 (3 rechts, 4 links)</td></tr><tr><td>Tumoranteil gesamt</td><td>35%</td></tr><tr><td>Tumorlänge gesamt</td><td>18,5 mm</td></tr><tr><td>Anteil Gleason 4/5</td><td>77%</td></tr><tr><td>Perineurale Infiltration</td><td>Nachgewiesen</td></tr><tr><td>Periprostatische Fettinvasion</td><td>Nachgewiesen (apikal)</td></tr><tr><td>Samenblaseninfiltration</td><td>Nicht nachgewiesen</td></tr><tr><td>Lymphovaskuläre Invasion</td><td>Nicht nachgewiesen</td></tr><tr><td>Intraduktales Karzinom</td><td>Nicht nachgewiesen</td></tr><tr><td>ASAP</td><td>Nein</td></tr><tr><td>High-grade-PIN</td><td>Nicht nachgewiesen</td></tr></tbody></table></div><hr/><h2>Additional Resources Included in Document</h2><a name="http-//prostatecancerspec.org/Patient/Patient1"> </a><a name="Patient_Patient1"> </a><a name="hcPatient_Patient1"> </a><hr/><p>Entry 2 - fullUrl = http://prostatecancerspec.org/Patient/Patient1</p><p>Resso}:</p><blockquote><p class="res-header-id"/><p style="border: 1px #661aff solid; background-color: #e6e6ff; padding: 10px;">Hans Mueller  Male, DoB: 1955-08-15 ( http://example.hospital.de/patient-ids#PAT-2024-001)</p><hr/></blockquote><a name="http-//prostatecancerspec.org/Organization/PathologyLabOrganization"> </a><a name="Organization_PathologyLabOrganization"> </a><a name="hcOrganization_PathologyLabOrganization"> </a><hr/><p>Entry 3 - fullUrl = http://prostatecancerspec.org/Organization/PathologyLabOrganization</p><p>Resso}:</p><blockquote><p class="res-header-id"/><a name="CoreNeedleBiopsyDocument/PathologyLabOrganization"> </a><a name="hcCoreNeedleBiopsyDocument/PathologyLabOrganization"> </a><p><b>identifier</b>: <code>http://example.hospital.de/organization-ids</code>/ORG-PATH-001</p><p><b>name</b>: Pathologielabor</p></blockquote><a name="http-//prostatecancerspec.org/DiagnosticReport/CoreNeedleBiopsyReport"> </a><a name="DiagnosticReport_CoreNeedleBiopsyReport"> </a><a name="hcDiagnosticReport_CoreNeedleBiopsyReport"> </a><hr/><p>Entry 4 - fullUrl = http://prostatecancerspec.org/DiagnosticReport/CoreNeedleBiopsyReport</p><p>Resso}:</p><blockquote><p class="res-header-id"/><a name="CoreNeedleBiopsyDocument/CoreNeedleBiopsyReport"> </a><a name="hcCoreNeedleBiopsyDocument/CoreNeedleBiopsyReport"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="https://simplifier.net/resolve?scope=de.medizininformatikinitiative.kerndatensatz.patho@2026.0.0&amp;canonical=https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/StructureDefinition/mii-pr-patho-report">MII PR Patho Reportversion: null2026.0.0)</a></p></div><h2><span title="Codes:{http://loinc.org 60568-3}">Pathology Synoptic report</span> (<span title="Codes:{http://terminology.hl7.org/CodeSystem/v2-0074 SP}">Surgical Pathology</span>) </h2><table class="grid"><tr><td>Subject</td><td>Hans Mueller  Male, DoB: 1955-08-15 ( http://example.hospital.de/patient-ids#PAT-2024-001)</td></tr><tr><td>When For</td><td>2024-01-20 15:00:00+0100</td></tr><tr><td>Reported</td><td>2024-01-20 15:30:00+0100</td></tr><tr><td>Performer</td><td> <a href="Practitioner-PathologistPractitioner.html">Practitioner Maria Schneider </a></td></tr><tr><td>Identifier</td><td> Accession ID/E_24_001</td></tr></table><p><b>Report Details</b></p><table class="grid"><tr><td><b>Code</b></td><td><b>Value</b></td><td><b>Flags</b></td><td><b>Note</b></td><td><b>When For</b></td></tr><tr><td><a href="Observation-CoreNeedleBiopsyMacroscopicGrouper.html"><span title="Codes:{http://loinc.org 22634-0}">Pathology report gross observation Narrative</span></a> (<span title="Codes:{http://snomed.info/sct 41216001}">Prostatic structure (body structure)</span>)</td><td>Makroskopische Messungen aller 12 Prostatastanzen</td><td>Final</td><td><blockquote><div><p>Makroskopische Messungen für alle 12 Prostatastanzen: Längen 1.3-1.9cm, je 1 Zylinder pro Specimen. Stanzen 01-06 aus rechter Prostataregion, Stanzen 07-12 aus linker Prostataregion.</p>
</div></blockquote></td><td>2024-01-15 14:00:00+0100</td></tr><tr><td><a href="Observation-CoreNeedleBiopsyMicroscopicGrouper.html"><span title="Codes:{http://loinc.org 22635-7}">Pathology report microscopic observation Narrative Other stain</span></a> (<span title="Codes:{http://snomed.info/sct 41216001}">Prostatic structure (body structure)</span>)</td><td>Mikroskopische Befunde aller 12 Prostatastanzen</td><td>Final</td><td><blockquote><div><p>Mikroskopische Untersuchung der 12 Prostatastanzen: Adenokarzinom in 6 von 12 Stanzen nachgewiesen. Gleason Scores von 3+3=6 bis 4+5=9. Benigne Befunde in Stanzen 03, 05, 08, 10, 12. Detaillierte Findings für alle 16 Parameter pro Stanze implementiert.</p>
</div></blockquote></td><td>2024-01-17 10:00:00+0100</td></tr><tr><td><a href="Observation-CoreNeedleBiopsyDiagnosticConclusionGrouper.html"><span title="Codes:{http://loinc.org 22637-3}">Pathology report final diagnosis Narrative</span></a></td><td/><td>Final</td><td><blockquote><div><p>Diagnose: Azinäres Adenokarzinom der Prostata (ICD-O 8140/3). Gleason-Score 3+4=7a, ISUP-Gradgruppe 2 (WHO 2016). 7 von 12 Stanzen tumorbefallen (3 rechts, 4 links), prozentualer Tumoranteil 35%, Tumorlänge gesamt 18,5 mm. Perineurale Infiltration nachgewiesen. Infiltration des periprostatischen Fettgewebes apikal nachgewiesen (Hinweis auf extraprostatische Ausbreitung). Samenblaseninfiltration, lymphovaskuläre Invasion, intraduktales Karzinom, ASAP, High-grade-PIN und granulomatöse Prostatitis nicht nachgewiesen.</p>
</div></blockquote>By Practitioner/PathologistPractitioner @2023-03-15</td><td>2023-03-15</td></tr></table><div><p>Adenokarzinom der Prostata, Gleason-Score 7a (3+4) in 7 von 12 Stanzen, mit perineuralem Befall.</p>
</div></blockquote><a name="http-//prostatecancerspec.org/Observation/CoreNeedleBiopsyDiagnosticConclusionGrouper"> </a><a name="Observation_CoreNeedleBiopsyDiagnosticConclusionGrouper"> </a><a name="hcObservation_CoreNeedleBiopsyDiagnosticConclusionGrouper"> </a><hr/><p>Entry 5 - fullUrl = http://prostatecancerspec.org/Observation/CoreNeedleBiopsyDiagnosticConclusionGrouper</p><p>Resso}:</p><blockquote><p class="res-header-id"/><a name="CoreNeedleBiopsyDocument/CoreNeedleBiopsyDiagnosticConclusionGrouper"> </a><a name="hcCoreNeedleBiopsyDocument/CoreNeedleBiopsyDiagnosticConclusionGrouper"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="https://simplifier.net/resolve?scope=de.medizininformatikinitiative.kerndatensatz.patho@2026.0.0&amp;canonical=https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/StructureDefinition/mii-pr-patho-diagnostic-conclusion-grouper">MII PR Patho Diagnostic Conclusion Grouperversion: null2026.0.0)</a></p></div><p><b>basedOn</b>: <a href="ServiceRequest-CoreNeedleBiopsyReportRequest.html">ServiceRequest Prostate Pathology biopsy report</a></p><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/observation-category laboratory}">Laboratory</span></p><p><b>code</b>: <span title="Codes:{http://loinc.org 22637-3}">Pathology report final diagnosis Narrative</span></p><p><b>subject</b>: <a href="Patient-Patient1.html">Hans Mueller  Male, DoB: 1955-08-15 ( http://example.hospital.de/patient-ids#PAT-2024-001)</a></p><p><b>effective</b>: 2023-03-15</p><p><b>performer</b>: <a href="Practitioner-PathologistPractitioner.html">Practitioner Maria Schneider </a></p><p><b>note</b>: By Practitioner/PathologistPractitioner @2023-03-15</p><blockquote><div><p>Diagnose: Azinäres Adenokarzinom der Prostata (ICD-O 8140/3). Gleason-Score 3+4=7a, ISUP-Gradgruppe 2 (WHO 2016). 7 von 12 Stanzen tumorbefallen (3 rechts, 4 links), prozentualer Tumoranteil 35%, Tumorlänge gesamt 18,5 mm. Perineurale Infiltration nachgewiesen. Infiltration des periprostatischen Fettgewebes apikal nachgewiesen (Hinweis auf extraprostatische Ausbreitung). Samenblaseninfiltration, lymphovaskuläre Invasion, intraduktales Karzinom, ASAP, High-grade-PIN und granulomatöse Prostatitis nicht nachgewiesen.</p>
</div></blockquote><p><b>hasMember</b>: </p><ul><li><a href="Observation-CoreNeedleBiopsyHistologicalTypeICDO3.html">Observation Histology and Behavior ICD-O-3 Cancer</a></li><li><a href="Observation-CoreNeedleBiopsyMorphologyFreeText.html">Observation Histology type in Cancer specimen Narrative</a></li><li><a href="Observation-CoreNeedleBiopsyICDOVersion.html">Observation World Health Organization tumor classification (observable entity)</a></li><li><a href="Observation-CoreNeedleBiopsyPrimaryGleasonPattern.html">Observation Gleason pattern.primary in Prostate tumor</a></li><li><a href="Observation-CoreNeedleBiopsySecondaryGleasonPattern.html">Observation Gleason pattern.secondary in Prostate tumor</a></li><li><a href="Observation-CoreNeedleBiopsyGleasonScoreTotal.html">Observation Gleason score in Specimen Qualitative</a></li><li><a href="Observation-CoreNeedleBiopsyPercentageGleason45.html">Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area</a></li><li><a href="Observation-CoreNeedleBiopsyGradingGroupISUP.html">Observation Prostate cancer grade group [Score] in Prostate tumor Qualitative</a></li><li><a href="Observation-CoreNeedleBiopsyHistologicalGradeWHO.html">Observation Grade Cancer</a></li><li><a href="Observation-CoreNeedleBiopsyPositiveCoresRight.html">Observation Number of tissue cores positive for carcinoma where In = Structure of right lateral lobe of prostate</a></li><li><a href="Observation-CoreNeedleBiopsyPositiveCoresLeft.html">Observation Number of tissue cores positive for carcinoma where In = Structure of left lateral lobe of prostate</a></li><li><a href="Observation-CoreNeedleBiopsyRatioPositiveCores.html">Observation Ratio of blocks with prostate tumor to total number of blocks obtained (observable entity)</a></li><li><a href="Observation-CoreNeedleBiopsyPercentageTumorTotal.html">Observation Tissue cores.positive.carcinoma in Tissue core</a></li><li><a href="Observation-CoreNeedleBiopsyTumorLengthTotal.html">Observation Total linear mm of carcinoma</a></li><li><a href="Observation-CoreNeedleBiopsyPerineuralInfiltration.html">Observation Perineural invasion [Presence] in Cancer specimen</a></li><li><a href="Observation-CoreNeedleBiopsySeminalVesicleInvasion.html">Observation Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyLymphovascularInvasion.html">Observation Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyPeriprostataticFatInvasion.html">Observation Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyExtraprostaticExtensionLocation.html">Observation Extraprostatic extension site [Anatomy] of Prostate tumor</a></li><li><a href="Observation-CoreNeedleBiopsyIntraductalCarcinoma.html">Observation Non-infiltrating intraductal carcinoma (morphologic abnormality)</a></li><li><a href="Observation-CoreNeedleBiopsyASAP.html">Observation Atypical small acinar proliferation of prostate (disorder)</a></li><li><a href="Observation-CoreNeedleBiopsyHighGradePIN.html">Observation High grade prostatic intraepithelial neoplasia</a></li><li><a href="Observation-CoreNeedleBiopsyGranulomatousProstatiti.html">Observation Granulomatous prostatitis</a></li></ul><p><b>derivedFrom</b>: </p><ul><li><a href="Observation-CoreNeedleBiopsyPrimaerGleason01.html">Observation Gleason pattern.primary in Prostate tumor</a></li><li><a href="Observation-CoreNeedleBiopsySekundaerGleason01.html">Observation Gleason pattern.secondary in Prostate tumor</a></li><li><a href="Observation-CoreNeedleBiopsyPrimaerGleason02.html">Observation Gleason pattern.primary in Prostate tumor</a></li><li><a href="Observation-CoreNeedleBiopsySekundaerGleason02.html">Observation Gleason pattern.secondary in Prostate tumor</a></li><li><a href="Observation-CoreNeedleBiopsyProzentGleason01.html">Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area [Area Fraction] in Prostate tumor by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyProzentGleason02.html">Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area [Area Fraction] in Prostate tumor by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyGleasonGrading01.html">Observation Histologic grade of primary malignant neoplasm of prostate by International Society of Urological Pathology technique (observable entity)</a></li><li><a href="Observation-CoreNeedleBiopsyGleasonGrading02.html">Observation Prostate cancer grade group [Score] in Prostate tumor Qualitative</a></li><li><a href="Observation-CoreNeedleBiopsyVerhaeltnisPositiverStanzen01.html">Observation Ratio of blocks with prostate tumor to total number of blocks obtained (observable entity)</a></li><li><a href="Observation-CoreNeedleBiopsyVerhaeltnisPositiverStanzen02.html">Observation Ratio of blocks with prostate tumor to total number of blocks obtained (observable entity)</a></li><li><a href="Observation-CoreNeedleBiopsyTumoranteil01.html">Observation Percentage of prostatic tissue, obtained by needle biopsy, involved by carcinoma (observable entity)</a></li><li><a href="Observation-CoreNeedleBiopsyTumoranteil02.html">Observation Percentage of prostatic tissue, obtained by needle biopsy, involved by carcinoma (observable entity)</a></li><li><a href="Observation-CoreNeedleBiopsyTumorbefallinLaenge01.html">Observation Total linear mm of carcinoma</a></li><li><a href="Observation-CoreNeedleBiopsyTumorbefallinLaenge02.html">Observation Total linear mm of carcinoma</a></li><li><a href="Observation-CoreNeedleBiopsyPerineuraleInfiltration01.html">Observation Perineural invasion [Presence] in Cancer specimen</a></li><li><a href="Observation-CoreNeedleBiopsyPerineuraleInfiltration02.html">Observation Perineural invasion [Presence] in Cancer specimen</a></li><li><a href="Observation-CoreNeedleBiopsyHighGradePIN01.html">Observation High grade prostatic intraepithelial neoplasia [Presence] in Specimen by Microscopy</a></li></ul></blockquote><a name="http-//prostatecancerspec.org/Observation/CoreNeedleBiopsyMacroscopicGrouper"> </a><a name="Observation_CoreNeedleBiopsyMacroscopicGrouper"> </a><a name="hcObservation_CoreNeedleBiopsyMacroscopicGrouper"> </a><hr/><p>Entry 6 - fullUrl = http://prostatecancerspec.org/Observation/CoreNeedleBiopsyMacroscopicGrouper</p><p>Resso}:</p><blockquote><p class="res-header-id"/><a name="CoreNeedleBiopsyDocument/CoreNeedleBiopsyMacroscopicGrouper"> </a><a name="hcCoreNeedleBiopsyDocument/CoreNeedleBiopsyMacroscopicGrouper"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="https://simplifier.net/resolve?scope=de.medizininformatikinitiative.kerndatensatz.patho@2026.0.0&amp;canonical=https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/StructureDefinition/mii-pr-patho-macroscopic-grouper">MII PR Patho Macroscopic Grouperversion: null2026.0.0)</a></p></div><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/observation-category laboratory}">Laboratory</span></p><p><b>code</b>: <span title="Codes:{http://loinc.org 22634-0}">Pathology report gross observation Narrative</span></p><p><b>subject</b>: <a href="Patient-Patient1.html">Hans Mueller  Male, DoB: 1955-08-15 ( http://example.hospital.de/patient-ids#PAT-2024-001)</a></p><p><b>effective</b>: 2024-01-15 14:00:00+0100</p><p><b>performer</b>: <a href="Practitioner-PathologistPractitioner.html">Practitioner Maria Schneider </a></p><p><b>value</b>: Makroskopische Messungen aller 12 Prostatastanzen</p><p><b>note</b>: </p><blockquote><div><p>Makroskopische Messungen für alle 12 Prostatastanzen: Längen 1.3-1.9cm, je 1 Zylinder pro Specimen. Stanzen 01-06 aus rechter Prostataregion, Stanzen 07-12 aus linker Prostataregion.</p>
</div></blockquote><p><b>bodySite</b>: <span title="Codes:{http://snomed.info/sct 41216001}">Prostatic structure (body structure)</span></p><p><b>derivedFrom</b>: </p><ul><li><a href="Observation-CoreNeedleBiopsyMacroscopicLength01.html">Observation Length of tissue core(s)</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLength02.html">Observation Length of tissue core(s)</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLength03.html">Observation Length of tissue core(s)</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLength04.html">Observation Length of tissue core(s)</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLength05.html">Observation Length of tissue core(s)</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLength06.html">Observation Length of tissue core(s)</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLength07.html">Observation Length of tissue core(s)</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLength08.html">Observation Length of tissue core(s)</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLength09.html">Observation Length of tissue core(s)</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLength10.html">Observation Length of tissue core(s)</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLength11.html">Observation Length of tissue core(s)</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLength12.html">Observation Length of tissue core(s)</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicCylinderCount01.html">Observation Total number of cores in Tissue core</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicCylinderCount02.html">Observation Total number of cores in Tissue core</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicCylinderCount03.html">Observation Total number of cores in Tissue core</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicCylinderCount04.html">Observation Total number of cores in Tissue core</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicCylinderCount05.html">Observation Total number of cores in Tissue core</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicCylinderCount06.html">Observation Total number of cores in Tissue core</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicCylinderCount07.html">Observation Total number of cores in Tissue core</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicCylinderCount08.html">Observation Total number of cores in Tissue core</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicCylinderCount09.html">Observation Total number of cores in Tissue core</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicCylinderCount10.html">Observation Total number of cores in Tissue core</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicCylinderCount11.html">Observation Total number of cores in Tissue core</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicCylinderCount12.html">Observation Total number of cores in Tissue core</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLaterality01.html">Observation Laterality</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLaterality02.html">Observation Laterality</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLaterality03.html">Observation Laterality</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLaterality04.html">Observation Laterality</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLaterality05.html">Observation Laterality</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLaterality06.html">Observation Laterality</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLaterality07.html">Observation Laterality</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLaterality08.html">Observation Laterality</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLaterality09.html">Observation Laterality</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLaterality10.html">Observation Laterality</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLaterality11.html">Observation Laterality</a></li><li><a href="Observation-CoreNeedleBiopsyMacroscopicLaterality12.html">Observation Laterality</a></li></ul></blockquote><a name="http-//prostatecancerspec.org/Observation/CoreNeedleBiopsyMicroscopicGrouper"> </a><a name="Observation_CoreNeedleBiopsyMicroscopicGrouper"> </a><a name="hcObservation_CoreNeedleBiopsyMicroscopicGrouper"> </a><hr/><p>Entry 7 - fullUrl = http://prostatecancerspec.org/Observation/CoreNeedleBiopsyMicroscopicGrouper</p><p>Resso}:</p><blockquote><p class="res-header-id"/><a name="CoreNeedleBiopsyDocument/CoreNeedleBiopsyMicroscopicGrouper"> </a><a name="hcCoreNeedleBiopsyDocument/CoreNeedleBiopsyMicroscopicGrouper"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="https://simplifier.net/resolve?scope=de.medizininformatikinitiative.kerndatensatz.patho@2026.0.0&amp;canonical=https://www.medizininformatik-initiative.de/fhir/ext/modul-patho/StructureDefinition/mii-pr-patho-microscopic-grouper">MII PR Patho Microscopic Grouperversion: null2026.0.0)</a></p></div><p><b>status</b>: Final</p><p><b>category</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/observation-category laboratory}">Laboratory</span></p><p><b>code</b>: <span title="Codes:{http://loinc.org 22635-7}">Pathology report microscopic observation Narrative Other stain</span></p><p><b>subject</b>: <a href="Patient-Patient1.html">Hans Mueller  Male, DoB: 1955-08-15 ( http://example.hospital.de/patient-ids#PAT-2024-001)</a></p><p><b>effective</b>: 2024-01-17 10:00:00+0100</p><p><b>performer</b>: <a href="Practitioner-PathologistPractitioner.html">Practitioner Maria Schneider </a></p><p><b>value</b>: Mikroskopische Befunde aller 12 Prostatastanzen</p><p><b>note</b>: </p><blockquote><div><p>Mikroskopische Untersuchung der 12 Prostatastanzen: Adenokarzinom in 6 von 12 Stanzen nachgewiesen. Gleason Scores von 3+3=6 bis 4+5=9. Benigne Befunde in Stanzen 03, 05, 08, 10, 12. Detaillierte Findings für alle 16 Parameter pro Stanze implementiert.</p>
</div></blockquote><p><b>bodySite</b>: <span title="Codes:{http://snomed.info/sct 41216001}">Prostatic structure (body structure)</span></p><p><b>derivedFrom</b>: </p><ul><li><a href="Observation-CoreNeedleBiopsyHistoTyp01.html">Observation Histology and Behavior ICD-O-3 Cancer</a></li><li><a href="Observation-CoreNeedleBiopsyMorphText01.html">Observation Histology type in Cancer specimen Narrative</a></li><li><a href="Observation-CoreNeedleBiopsyPrimaerGleason01.html">Observation Gleason pattern.primary in Prostate tumor</a></li><li><a href="Observation-CoreNeedleBiopsySekundaerGleason01.html">Observation Gleason pattern.secondary in Prostate tumor</a></li><li><a href="Observation-CoreNeedleBiopsyProzentGleason01.html">Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area [Area Fraction] in Prostate tumor by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyGleasonGrading01.html">Observation Histologic grade of primary malignant neoplasm of prostate by International Society of Urological Pathology technique (observable entity)</a></li><li><a href="Observation-CoreNeedleBiopsyVerhaeltnisPositiverStanzen01.html">Observation Ratio of blocks with prostate tumor to total number of blocks obtained (observable entity)</a></li><li><a href="Observation-CoreNeedleBiopsyTumoranteil01.html">Observation Percentage of prostatic tissue, obtained by needle biopsy, involved by carcinoma (observable entity)</a></li><li><a href="Observation-CoreNeedleBiopsyTumorbefallinLaenge01.html">Observation Total linear mm of carcinoma</a></li><li><a href="Observation-CoreNeedleBiopsyPerineuraleInfiltration01.html">Observation Perineural invasion [Presence] in Cancer specimen</a></li><li><a href="Observation-CoreNeedleBiopsyTumornachweisinSamenblase01.html">Observation Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyLymphovaskulaereInvasion01.html">Observation Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyTumornachweisInFettgewebe01.html">Observation Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyIntraduktalesKarzinom01.html">Observation Non-infiltrating intraductal carcinoma (morphologic abnormality)</a></li><li><a href="Observation-CoreNeedleBiopsyASAP01.html">Observation Atypical small acinar proliferation of prostate (disorder)</a></li><li><a href="Observation-CoreNeedleBiopsyHighGradePIN01.html">Observation High grade prostatic intraepithelial neoplasia [Presence] in Specimen by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyGranulomatoeseProstatitis01.html">Observation Granulomatous prostatitis [Presence] in Specimen by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyHistoTyp02.html">Observation Histology and Behavior ICD-O-3 Cancer</a></li><li><a href="Observation-CoreNeedleBiopsyMorphText02.html">Observation Histology type in Cancer specimen Narrative</a></li><li><a href="Observation-CoreNeedleBiopsyPrimaerGleason02.html">Observation Gleason pattern.primary in Prostate tumor</a></li><li><a href="Observation-CoreNeedleBiopsySekundaerGleason02.html">Observation Gleason pattern.secondary in Prostate tumor</a></li><li><a href="Observation-CoreNeedleBiopsyProzentGleason02.html">Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area [Area Fraction] in Prostate tumor by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyGleasonGrading02.html">Observation Prostate cancer grade group [Score] in Prostate tumor Qualitative</a></li><li><a href="Observation-CoreNeedleBiopsyVerhaeltnisPositiverStanzen02.html">Observation Ratio of blocks with prostate tumor to total number of blocks obtained (observable entity)</a></li><li><a href="Observation-CoreNeedleBiopsyTumoranteil02.html">Observation Percentage of prostatic tissue, obtained by needle biopsy, involved by carcinoma (observable entity)</a></li><li><a href="Observation-CoreNeedleBiopsyTumorbefallinLaenge02.html">Observation Total linear mm of carcinoma</a></li><li><a href="Observation-CoreNeedleBiopsyPerineuraleInfiltration02.html">Observation Perineural invasion [Presence] in Cancer specimen</a></li><li><a href="Observation-CoreNeedleBiopsyTumornachweisinSamenblase02.html">Observation Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyLymphovaskulaereInvasion02.html">Observation Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyTumornachweisInFettgewebe02.html">Observation Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyIntraduktalesKarzinom02.html">Observation Non-infiltrating intraductal carcinoma (morphologic abnormality)</a></li><li><a href="Observation-CoreNeedleBiopsyASAP02.html">Observation Atypical small acinar proliferation of prostate (disorder)</a></li><li><a href="Observation-CoreNeedleBiopsyHighGradePIN02.html">Observation High grade prostatic intraepithelial neoplasia [Presence] in Specimen by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyGranulomatoeseProstatitis02.html">Observation Granulomatous prostatitis [Presence] in Specimen by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyHistoTyp03.html">Observation Histology and Behavior ICD-O-3 Cancer</a></li><li><a href="Observation-CoreNeedleBiopsyMorphText03.html">Observation Histology type in Cancer specimen Narrative</a></li><li><a href="Observation-CoreNeedleBiopsyHistoTyp04.html">Observation Histology and Behavior ICD-O-3 Cancer</a></li><li><a href="Observation-CoreNeedleBiopsyMorphText04.html">Observation Histology type in Cancer specimen Narrative</a></li><li><a href="Observation-CoreNeedleBiopsyPrimaerGleason04.html">Observation Gleason pattern.primary in Prostate tumor</a></li><li><a href="Observation-CoreNeedleBiopsySekundaerGleason04.html">Observation Gleason pattern.secondary in Prostate tumor</a></li><li><a href="Observation-CoreNeedleBiopsyProzentGleason04.html">Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area [Area Fraction] in Prostate tumor by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyGleasonGrading04.html">Observation Prostate cancer grade group [Score] in Prostate tumor Qualitative</a></li><li><a href="Observation-CoreNeedleBiopsyVerhaeltnisPositiverStanzen04.html">Observation Ratio of blocks with prostate tumor to total number of blocks obtained (observable entity)</a></li><li><a href="Observation-CoreNeedleBiopsyTumoranteil04.html">Observation Percentage of prostatic tissue, obtained by needle biopsy, involved by carcinoma (observable entity)</a></li><li><a href="Observation-CoreNeedleBiopsyTumorbefallinLaenge04.html">Observation Total linear mm of carcinoma</a></li><li><a href="Observation-CoreNeedleBiopsyPerineuraleInfiltration04.html">Observation Perineural invasion [Presence] in Cancer specimen</a></li><li><a href="Observation-CoreNeedleBiopsyTumornachweisinSamenblase04.html">Observation Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyLymphovaskulaereInvasion04.html">Observation Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyTumornachweisInFettgewebe04.html">Observation Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyIntraduktalesKarzinom04.html">Observation Non-infiltrating intraductal carcinoma (morphologic abnormality)</a></li><li><a href="Observation-CoreNeedleBiopsyASAP04.html">Observation Atypical small acinar proliferation of prostate (disorder)</a></li><li><a href="Observation-CoreNeedleBiopsyHighGradePIN04.html">Observation High grade prostatic intraepithelial neoplasia [Presence] in Specimen by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyGranulomatoeseProstatitis04.html">Observation Granulomatous prostatitis [Presence] in Specimen by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyHistoTyp05.html">Observation Histology and Behavior ICD-O-3 Cancer</a></li><li><a href="Observation-CoreNeedleBiopsyMorphText05.html">Observation Histology type in Cancer specimen Narrative</a></li><li><a href="Observation-CoreNeedleBiopsyHistoTyp06.html">Observation Histology and Behavior ICD-O-3 Cancer</a></li><li><a href="Observation-CoreNeedleBiopsyMorphText06.html">Observation Histology type in Cancer specimen Narrative</a></li><li><a href="Observation-CoreNeedleBiopsyPrimaerGleason06.html">Observation Gleason pattern.primary in Prostate tumor</a></li><li><a href="Observation-CoreNeedleBiopsySekundaerGleason06.html">Observation Gleason pattern.secondary in Prostate tumor</a></li><li><a href="Observation-CoreNeedleBiopsyProzentGleason06.html">Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area [Area Fraction] in Prostate tumor by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyGleasonGrading06.html">Observation Prostate cancer grade group [Score] in Prostate tumor Qualitative</a></li><li><a href="Observation-CoreNeedleBiopsyVerhaeltnisPositiverStanzen06.html">Observation Ratio of blocks with prostate tumor to total number of blocks obtained (observable entity)</a></li><li><a href="Observation-CoreNeedleBiopsyTumoranteil06.html">Observation Percentage of prostatic tissue, obtained by needle biopsy, involved by carcinoma (observable entity)</a></li><li><a href="Observation-CoreNeedleBiopsyTumorbefallinLaenge06.html">Observation Total linear mm of carcinoma</a></li><li><a href="Observation-CoreNeedleBiopsyPerineuraleInfiltration06.html">Observation Perineural invasion [Presence] in Cancer specimen</a></li><li><a href="Observation-CoreNeedleBiopsyTumornachweisinSamenblase06.html">Observation Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyLymphovaskulaereInvasion06.html">Observation Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyTumornachweisInFettgewebe06.html">Observation Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyIntraduktalesKarzinom06.html">Observation Non-infiltrating intraductal carcinoma (morphologic abnormality)</a></li><li><a href="Observation-CoreNeedleBiopsyASAP06.html">Observation Atypical small acinar proliferation of prostate (disorder)</a></li><li><a href="Observation-CoreNeedleBiopsyHighGradePIN06.html">Observation High grade prostatic intraepithelial neoplasia [Presence] in Specimen by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyGranulomatoeseProstatitis06.html">Observation Granulomatous prostatitis [Presence] in Specimen by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyHistoTyp07.html">Observation Histology and Behavior ICD-O-3 Cancer</a></li><li><a href="Observation-CoreNeedleBiopsyMorphText07.html">Observation Histology type in Cancer specimen Narrative</a></li><li><a href="Observation-CoreNeedleBiopsyPrimaerGleason07.html">Observation Gleason pattern.primary in Prostate tumor</a></li><li><a href="Observation-CoreNeedleBiopsySekundaerGleason07.html">Observation Gleason pattern.secondary in Prostate tumor</a></li><li><a href="Observation-CoreNeedleBiopsyProzentGleason07.html">Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area [Area Fraction] in Prostate tumor by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyGleasonGrading07.html">Observation Prostate cancer grade group [Score] in Prostate tumor Qualitative</a></li><li><a href="Observation-CoreNeedleBiopsyVerhaeltnisPositiverStanzen07.html">Observation Ratio of blocks with prostate tumor to total number of blocks obtained (observable entity)</a></li><li><a href="Observation-CoreNeedleBiopsyTumoranteil07.html">Observation Percentage of prostatic tissue, obtained by needle biopsy, involved by carcinoma (observable entity)</a></li><li><a href="Observation-CoreNeedleBiopsyTumorbefallinLaenge07.html">Observation Total linear mm of carcinoma</a></li><li><a href="Observation-CoreNeedleBiopsyPerineuraleInfiltration07.html">Observation Perineural invasion [Presence] in Cancer specimen</a></li><li><a href="Observation-CoreNeedleBiopsyTumornachweisinSamenblase07.html">Observation Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyLymphovaskulaereInvasion07.html">Observation Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyTumornachweisInFettgewebe07.html">Observation Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyIntraduktalesKarzinom07.html">Observation Non-infiltrating intraductal carcinoma (morphologic abnormality)</a></li><li><a href="Observation-CoreNeedleBiopsyASAP07.html">Observation Atypical small acinar proliferation of prostate (disorder)</a></li><li><a href="Observation-CoreNeedleBiopsyHighGradePIN07.html">Observation High grade prostatic intraepithelial neoplasia [Presence] in Specimen by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyGranulomatoeseProstatitis07.html">Observation Granulomatous prostatitis [Presence] in Specimen by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyHistoTyp08.html">Observation Histology and Behavior ICD-O-3 Cancer</a></li><li><a href="Observation-CoreNeedleBiopsyMorphText08.html">Observation Histology type in Cancer specimen Narrative</a></li><li><a href="Observation-CoreNeedleBiopsyHistoTyp09.html">Observation Histology and Behavior ICD-O-3 Cancer</a></li><li><a href="Observation-CoreNeedleBiopsyMorphText09.html">Observation Histology type in Cancer specimen Narrative</a></li><li><a href="Observation-CoreNeedleBiopsyPrimaerGleason09.html">Observation Gleason pattern.primary in Prostate tumor</a></li><li><a href="Observation-CoreNeedleBiopsySekundaerGleason09.html">Observation Gleason pattern.secondary in Prostate tumor</a></li><li><a href="Observation-CoreNeedleBiopsyProzentGleason09.html">Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area [Area Fraction] in Prostate tumor by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyGleasonGrading09.html">Observation Prostate cancer grade group [Score] in Prostate tumor Qualitative</a></li><li><a href="Observation-CoreNeedleBiopsyVerhaeltnisPositiverStanzen09.html">Observation Ratio of blocks with prostate tumor to total number of blocks obtained (observable entity)</a></li><li><a href="Observation-CoreNeedleBiopsyTumoranteil09.html">Observation Percentage of prostatic tissue, obtained by needle biopsy, involved by carcinoma (observable entity)</a></li><li><a href="Observation-CoreNeedleBiopsyTumorbefallinLaenge09.html">Observation Total linear mm of carcinoma</a></li><li><a href="Observation-CoreNeedleBiopsyPerineuraleInfiltration09.html">Observation Perineural invasion [Presence] in Cancer specimen</a></li><li><a href="Observation-CoreNeedleBiopsyTumornachweisinSamenblase09.html">Observation Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyLymphovaskulaereInvasion09.html">Observation Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyTumornachweisInFettgewebe09.html">Observation Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyIntraduktalesKarzinom09.html">Observation Non-infiltrating intraductal carcinoma (morphologic abnormality)</a></li><li><a href="Observation-CoreNeedleBiopsyASAP09.html">Observation Atypical small acinar proliferation of prostate (disorder)</a></li><li><a href="Observation-CoreNeedleBiopsyHighGradePIN09.html">Observation High grade prostatic intraepithelial neoplasia [Presence] in Specimen by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyGranulomatoeseProstatitis09.html">Observation Granulomatous prostatitis [Presence] in Specimen by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyHistoTyp10.html">Observation Histology and Behavior ICD-O-3 Cancer</a></li><li><a href="Observation-CoreNeedleBiopsyMorphText10.html">Observation Histology type in Cancer specimen Narrative</a></li><li><a href="Observation-CoreNeedleBiopsyHistoTyp11.html">Observation Histology and Behavior ICD-O-3 Cancer</a></li><li><a href="Observation-CoreNeedleBiopsyMorphText11.html">Observation Histology type in Cancer specimen Narrative</a></li><li><a href="Observation-CoreNeedleBiopsyPrimaerGleason11.html">Observation Gleason pattern.primary in Prostate tumor</a></li><li><a href="Observation-CoreNeedleBiopsySekundaerGleason11.html">Observation Gleason pattern.secondary in Prostate tumor</a></li><li><a href="Observation-CoreNeedleBiopsyProzentGleason11.html">Observation Prostate tumor area with Gleason pattern 4+5/Total tumor area [Area Fraction] in Prostate tumor by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyGleasonGrading11.html">Observation Prostate cancer grade group [Score] in Prostate tumor Qualitative</a></li><li><a href="Observation-CoreNeedleBiopsyVerhaeltnisPositiverStanzen11.html">Observation Ratio of blocks with prostate tumor to total number of blocks obtained (observable entity)</a></li><li><a href="Observation-CoreNeedleBiopsyTumoranteil11.html">Observation Percentage of prostatic tissue, obtained by needle biopsy, involved by carcinoma (observable entity)</a></li><li><a href="Observation-CoreNeedleBiopsyTumorbefallinLaenge11.html">Observation Total linear mm of carcinoma</a></li><li><a href="Observation-CoreNeedleBiopsyPerineuraleInfiltration11.html">Observation Perineural invasion [Presence] in Cancer specimen</a></li><li><a href="Observation-CoreNeedleBiopsyTumornachweisinSamenblase11.html">Observation Seminal vesicle invasion [Identifier] in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyLymphovaskulaereInvasion11.html">Observation Venous + Lymphatic small vessel invasion in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyTumornachweisInFettgewebe11.html">Observation Periprostatic fat invasion [Identifier] in Specimen by CAP cancer protocols</a></li><li><a href="Observation-CoreNeedleBiopsyIntraduktalesKarzinom11.html">Observation Non-infiltrating intraductal carcinoma (morphologic abnormality)</a></li><li><a href="Observation-CoreNeedleBiopsyASAP11.html">Observation Atypical small acinar proliferation of prostate (disorder)</a></li><li><a href="Observation-CoreNeedleBiopsyHighGradePIN11.html">Observation High grade prostatic intraepithelial neoplasia [Presence] in Specimen by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyGranulomatoeseProstatitis11.html">Observation Granulomatous prostatitis [Presence] in Specimen by Microscopy</a></li><li><a href="Observation-CoreNeedleBiopsyHistoTyp12.html">Observation Histology and Behavior ICD-O-3 Cancer</a></li><li><a href="Observation-CoreNeedleBiopsyMorphText12.html">Observation Histology type in Cancer specimen Narrative</a></li></ul></blockquote></div>

  

  <!-- insert notes if present -->
  



</div>
        </div>  <!-- /inner-wrapper -->
      </div>  <!-- /row -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-content -->

  <script type="text/javascript" src="assets/js/jquery.js"> </script>     <!-- note keep space here, otherwise it will be transformed to empty tag -> fails -->
  <script type="text/javascript" src="assets/js/jquery-ui.min.js"> </script>

  <script type="text/javascript" src="assets/js/window-hash.js"> </script>
  <a name="bottom"> </a>
  <div id="segment-footer" igtool="footer" class="segment">  <!-- segment-footer -->
    <div class="container">  <!-- container -->

      <div class="inner-wrapper">
        <p>
          IG &#169; 2025+ <a style="color:var(--footer-hyperlink-text-color)" href="http://example.org/example-publisher">BIH CEI</a>.  Package prostatecancerspec#0.1.0 based on <a style="color: var(--footer-hyperlink-text-color)" href="http://hl7.org/fhir/R4/">FHIR 4.0.1</a>. Generated <span title="Mon, Feb 9, 2026 11:01+0100">2026-02-09</span>
          <br/>
          <span style="color: var(--footer-highlight-text-color)">
                      Links: <a style="color: var(--footer-hyperlink-text-color)" href="toc.html">Table of Contents</a> |
                 <a style="color: var(--footer-hyperlink-text-color)" href="qa.html">QA Report</a>
                 
                
          </span>
        </p>
      </div>  <!-- /inner-wrapper -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-footer -->
  
  <div id="segment-post-footer" class="segment hidden">  <!-- segment-post-footer -->
    <div class="container">  <!-- container -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-post-footer -->

  <!-- JS and analytics only. -->
  <!-- Bootstrap core JavaScript
  ================================================== -->
  <!-- Placed at the end of the document so the pages load faster -->
  <script type="text/javascript" src="assets/js/bootstrap.min.js"> </script>
  <script type="text/javascript" src="assets/js/respond.min.js"> </script>
  <script type="text/javascript" src="assets/js/anchor.min.js"> </script>
  <script type="text/javascript" src="assets/js/clipboard.min.js"> </script>
  <script type="text/javascript" src="assets/js/clipboard-btn.js"> </script>
  <script type="text/javascript" src="assets/js/anchor-hover.js"> </script>
  <!-- Analytics Below
  ================================================== -->
  </body>
</html>

